Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Petkova, S. B. Articles by Roopenian, D. C. Search for Related Content PubMed PubMed Citation Articles by Petkova, S. B. Articles by Roopenian, D. C. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Medline Plus Health Information Joint Disorders Social Bookmarking                      What's this?

Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor FcRIIB

¹ The Jackson Laboratory, Bar Harbor, ME 04605
² Department of Internal Medicine, Division of Rheumatology, The University of New Mexico, Albuquerque, NM 87122

CORRESPONDENCE Derry C. Roopenian: dcr{at}jax.org

Rheumatoid arthritis (RA) is a complex autoimmune disease with a poorly understood pathogenesis. The disease is associated with polyclonal B cell activation and the production of autoantibodies (autoAbs), but there is a longstanding controversy as to whether such Abs contribute to, or are secondary to, the pathogenesis of RA. To address the potential pathogenicity of human RA–associated Abs, we developed a passive transfer model involving mice deficient in the low-affinity inhibitory Fc receptor, FcRIIB. We report that plasma or serum from patients with active RA can induce inflammation and histological lesions in FcRIIB^–/– mice consistent with arthritis, and that this pathogenic activity is caused by the immunoglobulin G–rich fraction. Our results suggest that humoral autoimmunity can contribute directly to autoimmune arthritis, and that FcRIIB^–/– mice are a promising model to evaluate the arthritogenic potential of human autoAbs.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

• Hamel, K., Doodes, P., Cao, Y., Wang, Y., Martinson, J., Dunn, R., Kehry, M. R., Farkas, B., Finnegan, A. (2008). Suppression of Proteoglycan-Induced Arthritis by Anti-CD20 B Cell Depletion Therapy Is Mediated by Reduction in Autoantibodies and CD4+ T Cell Reactivity. J. Immunol. 180: 4994-5003 [Abstract] [Full Text]  
• Maglione, P. J., Xu, J., Casadevall, A., Chan, J. (2008). Fc{gamma} Receptors Regulate Immune Activation and Susceptibility during Mycobacterium tuberculosis Infection. J. Immunol. 180: 3329-3338 [Abstract] [Full Text]  
• Petkova, S. B., Akilesh, S., Sproule, T. J., Christianson, G. J., Al Khabbaz, H., Brown, A. C., Presta, L. G., Meng, Y. G., Roopenian, D. C. (2006). Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. Int Immunol 18: 1759-1769 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS